Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Kristina Pearce
Moderna, Inc.
Poster(s):
(128) Safety of Moderna mRNA-1273.214 and mRNA-1273.222 COVID-19 bivalent vaccines: results from post-marketing surveillance in South Korea
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(279) Post-Marketing Safety Surveillance of Vaccines in Japan for Older Adults: A Feasibility Assessment of Real-World Data Capabilities
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
